Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$10.70
-4.97%
Mkt Cap $750.25M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+255.1%
Consensus $38.00 vs current $10.70
NASDAQ·Healthcare·Biotechnology
$10.70
-4.97%
Mkt Cap $750.25M
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+255.1%
Consensus $38.00 vs current $10.70